Showing 1,861 - 1,880 results of 4,658 for search 'significantly ((((((lower decrease) OR (nn decrease))) OR (linear decrease))) OR (teer decrease))', query time: 0.70s Refine Results
  1. 1861

    Primers for quantitative real-time PCR. by Ya-nan Hu (12508990)

    Published 2024
    “…However, LDLR protein levels in the cell lysate of both the Gly343Ser and Ala627Thr variants groups were significantly lower than those in the wild-type group. …”
  2. 1862

    Descriptive data for the pBT-child dyads. by Madalina Ciobanu (2504683)

    Published 2025
    “…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …”
  3. 1863

    CFQL-2 descriptive statistics. by Madalina Ciobanu (2504683)

    Published 2025
    “…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …”
  4. 1864

    O<sub>2</sub> concentration under different conditions. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  5. 1865

    This is the paper’s data. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  6. 1866

    O<sub>2</sub> concentration under different conditions. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  7. 1867
  8. 1868
  9. 1869
  10. 1870
  11. 1871
  12. 1872
  13. 1873
  14. 1874
  15. 1875
  16. 1876

    Participant flow (CONSORT diagram). by David J. Diemert (8135568)

    Published 2024
    “…Peak anti-<i>Na</i>-GST-1 IgG levels were observed between 2 and 4 weeks following the third dose, regardless of <i>Na</i>-GST-1 formulation. IgG levels decreased but remained significantly above baseline in all groups by day 290, at which point all participants (20 of 20 evaluable participants) still had detectable IgG. …”
  17. 1877
  18. 1878

    Study data. by Jie Liu (15128)

    Published 2025
    “…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…”
  19. 1879

    Summary of clinical outcomes after 9 months. by Jie Liu (15128)

    Published 2025
    “…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…”
  20. 1880

    Approval by the research ethics committee. by Jie Liu (15128)

    Published 2025
    “…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…”